City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border
  
  PROFILE 
The following is a list of available studies directed by  Melanie Palomares, MD, MS  
Search results:  3  Clinical trial(s) found  (Page 1 of 1 )
Results per page: 25 50 100 All 1-3 Trials Jump to page:

COH Protocol Number: 11313 ClinicalTrials.gov Number: NCT01097278

Principal Investigator: Melanie Palomares, MD, MS
Sponsor: Cooperative Group

Title:  SWOG S0812: Phase IIB Randomized Controlled Biomarker Modulation Study of Vitamin D in Premenopausal Women at High Risk for Breast Cancer

COH Protocol Number: 09181 ClinicalTrials.gov Number: NCT01121640

Principal Investigator: Melanie Palomares, MD, MS
Sponsor: NCI Approved External Peer Review

Title:  A Randomized Controlled Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women (Novel Markers Trial/NMT)

COH Protocol Number: 08218 ClinicalTrials.gov Number: NCT01196936

Principal Investigator: Melanie Palomares, MD, MS
Sponsor: NCI Approved External Peer Review

Title:  Low-Dose Tamoxifen for Radiation-Induced Breast Cancer Risk Reduction: A Phase IIB Randomized Placebo-Controlled Trial

 
Results per page: 25 50 100 All 1-3 Trials Jump to page:

 
 
  
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and gynecology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.